Hubei Haoxin Pharmaceutical Co., Ltd
Hubei Haoxin Pharmaceutical integrates R&D and production of Chinese and Western medicines, established in 2003 with $8M capital.
Introduction
Established in February 2003 with an initial registered capital of $8 million, Hubei Haoxin Pharmaceutical Co., Ltd. is a successful Sino-Hong Kong joint venture. This enterprise specializes in the research, development, and manufacturing of both original Chinese and Western medicine preparations, as well as pharmaceutical intermediates. Over the years, the company has produced a range of important drugs, including Erythromycin Huyi, Epistine Hydrochloride, Amisulpride, Irinotecan Hydrochloride, Anhydrous Paclitaxel, Dasatinib, Temozolomide, and Granisetron Hydrochloride.
Information
Categories
More Websites
Tianjin Hangu Hejia Chemical produces over 30,000 tons of caustic soda annually and manufactures various chemicals and plastics.
Online-analyzer using Sapphire and ceramic optics, fiber optics, Laser, and third-party spectrometers for concentration control.
QIAGEN offers sample and assay technologies for isolating and analyzing specific biomolecules from various samples.